Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP

Abstract

Cystatin C is a strong and independent predictor of outcome at 12 months in AHF. Furthermore, cystatin C identifies patients with poor prognosis despite normal plasma creatinine. Cystatin C seems to be a promising risk marker in patients hospitalized for AHF.